5 research outputs found

    HLA-DQA1*05 carriage associated with development of anti-drug antibodies to infliximab and adalimumab in patients with Crohn's Disease

    Get PDF
    Anti-tumor necrosis factor (anti-TNF) therapies are the most widely used biologic drugs for treating immune-mediated diseases, but repeated administration can induce the formation of anti-drug antibodies. The ability to identify patients at increased risk for development of anti-drug antibodies would facilitate selection of therapy and use of preventative strategies.This article is freely available via Open Access. Click on Publisher URL to access the full-text

    Escaping the everyday? Women's clothing on holiday

    No full text
    Includes bibliographical referencesAvailable from British Library Document Supply Centre- DSC:3830. 809999(no 6) / BLDSC - British Library Document Supply CentreSIGLEGBUnited Kingdo
    corecore